Doctor, biotech entrepreneur, and millionaire, Lindsay Rosenwald, is reportedly selling his New York City penthouse apartment for $65 million dollars. Located at the iconic luxury building, 15 Central Park West, the nearly 6,000 square foot space features stunning views of Central Park and an entire floor for entertaining guests.

Rosenwald has become very successful in recent years since becoming the Chief Executive Officer (CEO) of biopharmaceutical company, Fortress Biotech. Recently, at Rosenwald’s leadership, the company has forged two lucrative partnerships. One partnership is with AstraZeneca and the other is with the Cincinnati Children’s Hospital Medical Center.

The sale of Rosenwald’s 15 Central Park West apartment also has the potential to be very lucrative as well. If able to find a buyer, Lindsay Rosenwald will more than double his investment in the property.

About Lindsay Rosenwald

Dr. Lindsay Rosenwald is a medical doctor, biotechnology entrepreneur, and financial expert. He has a B.S. in Finance and Economy from Pennsylvania State University. Additionally, in 1983, he successfully graduated with his M.D. from Temple University School of Medicine.

His unique expertise in both financial markets and the medical field has certainly served him well throughout his life.

Over the course of his career, he has been a part of a number of projects in the pharmaceuticals and investment industries. Most recently since December of 2013, he has been President and Chief Executive Officer of Fortress Biotech. His role as a leader has been to help the company achieve financial success, exceed shareholder expectations, and build lucrative partnerships within the industry.

In addition to his role with Fortress Biotech, hs also serves as a director of Mustang Bio, Inc. and Checkpoint Therapeutics. He is also on the Board of Directors of Avenue Therapeutics, Inc.

About Fortress Biotech

According to the company website, Fortress Biotech’s purpose is ‘identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates.’

The company’s current product portfolio includes five prescription pharmaceuticals. Additionally, it has 25 more products in development stages.

Just last year in 2019, consulting giant Deloitte named Fortress Biotech as a top ten Technology Fast 500™ companies. This list ranks the ‘fastest-growing North American companies in the technology, media, telecommunications, life sciences, and energy tech sectors’. Deloitte uses the percentage of a company’s fiscal year revenue growth over 3 years to compile these rankings. Fortress Biotech was ranked in tenth place. 

One of the main ways that Fortress Biotech achieves growth and financial returns for investors is through partnerships.

These partnerships are typically with other pharmaceutical companies as well as academic and research institutions. Some of their high-profile partnerships include Alexion Pharmaceuticals, Inc., Fred Hutchinson Cancer Research Center, and InvaGen Pharmaceuticals Inc. They also have a partnership with St. Jude Children’s Research Hospital.

In 2019, Fortress Biotech stock, FIBO, grew 7.5% in December. This was likely due to the company’s announcement that it had reached a worldwide licensing agreement with AstraZeneca. The company also announced a new collaboration project with the Cincinnati Children’s Hospital Medical Center.

According to a press release issued on the Fortress Biotech website, the agreement with AstraZeneca is to license the drug, AZD7325. With Cincinnati Children’s Hospital Medical Center, they will work together ‘to advance clinical development in select central nervous systems (“CNS”) disorders’.

The company currently operates out of a 24,000 square-foot office space in Manhattan. According to reports, those who invested in the stock before December 24th profited by $1/share.

Rosenwald’s 5,000+ Square-foot Penthouse for Sale

Rosenwald is not only a great businessman at work with Fortress Biotech. He also has several successful investments in his private life; specifically in real estate.

One of these investments is located at 15 Central Park West in the affluent Upper West Side. The building was designed by renowned architect, Robert A.M. Stern and attracts high-end, luxury residents. Rosenwald’s corner penthouse in the building is nearly 6,000 square feet.

Located on the 18th and 19th floor, the apartment is modern, spacious, and luxurious.

According to the property listing, the apartment has two terraces that both face Central Park. One terrace reportedly ‘wraps around nearly the entire 18th floor’. Additionally, the apartment has a ‘private elevator, gas fireplace, individually zoned central ac/heat, custom closets plus motorized shades and awnings’.

The 18th floor of the property is designed perfectly for entertaining. It features a grand dining room, reception area, powder room, and full-size kitchen with extra space for service staff.

The 19th floor features the more private areas. These include a master bedroom suite with walk-in closets and dressing areas, a sitting room, and two additional full bathrooms. The master suite also features an outdoor balcony. Also on the 19th floor are three more bedrooms with ensuite bathrooms and a laundry room.

Other rooms in the apartment include a wine cellar, two storage units, a study/library, and a dining room. There is also a studio apartment/service suite fitted with a private closet, bathroom, and kitchenette.

Rosenwald originally purchased the property for $30.55 million, however it is currently worth double that amount. Rosenwald currently has the property listed at $65 million dollars.

The Neighborhood: 15 Central Park West

Lindsay Rosenwald has definitely fit in well at the exclusive 15 Central Park West facility.

The building itself boasts a number of luxury features and amenities loved by its high-income clientele. This includes a private restaurant, screening room, billiard room, and business center. There is also a health club, entertainment suite, and library. Other moguls and billionaires currently living at 15 Central Park West include Anheuser-Busch InBev shareholder, Marcel Herrmann Telles. Russian billionaire, Dmitry Rybolovlev, and his daughter also reportedly have a space there. Other residents include former CEO of Goldman Sachs, Lloyd Blankfein, and Chairman of Walt Disney Studios, Alan Horn, among others.

Write A Comment